In these trials, participants treated with Wegovy experienced substantial weight loss, making it a much-needed addition to the arsenal of obesity treatments
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are a type of medication originally developed to treat type 2 diabetes, but are now being used for the treatment of obesity because they are effective at helping people to lose weight
S2CID 33327108
This work was supported by the National Institutes of Health under award numbers 2R01HL115189, P30DK04056, UE5DK137285, and U24 DK132733, and by the National Clinician Scholars Program at the Duke Clinical and Translational Science Institute
Safety of exenatide once weekly in patients with type 2 diabetes mellitus treated with a thiazolidinedione alone or in combination with metformin for 2 years
These medications mimic the hormone glucagon-like peptide-1, which helps regulate appetite and insulin secretion, offering a powerful tool for those struggling with obesity or weight-related health conditions